Island Pharmaceuticals Shares Jump After U.S. Army Research Agreement Extended
Island Pharmaceuticals (ASX: ILA) shares rose as much as 5.7% on Wednesday after the company announced an extension of its cooperative research and development agreement with the U.S. Army. The arrangement backs a dose optimization study for Galidesivir, an experimental treatment being assessed for Marburg Virus Disease, and the company said the ex…